CDK11A
Basic information
Region (hg38): 1:1702379-1724357
Previous symbols: [ "CDC2L3", "CDC2L2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK11A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 46 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 47 | 7 | 0 |
Variants in CDK11A
This is a list of pathogenic ClinVar variants found in the CDK11A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-1703482-A-G | not specified | Uncertain significance (Jun 02, 2024) | ||
1-1703487-G-A | Likely benign (Mar 01, 2023) | |||
1-1703489-C-T | Likely benign (Oct 01, 2023) | |||
1-1703490-G-C | not specified | Uncertain significance (Jan 22, 2024) | ||
1-1703515-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
1-1703521-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
1-1703522-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
1-1703528-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
1-1703608-CT-C | not provided (-) | |||
1-1703882-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
1-1703906-C-G | not specified | Uncertain significance (Jun 13, 2024) | ||
1-1703917-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
1-1704062-G-C | not specified | Uncertain significance (Dec 19, 2022) | ||
1-1704065-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
1-1704068-G-A | not specified | Uncertain significance (May 31, 2023) | ||
1-1704076-T-A | Likely benign (Feb 01, 2023) | |||
1-1704094-G-C | not specified | Uncertain significance (Apr 26, 2024) | ||
1-1704112-G-T | not specified | Uncertain significance (Oct 12, 2022) | ||
1-1704124-C-T | not specified | Uncertain significance (May 24, 2023) | ||
1-1704133-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
1-1704135-A-G | Likely benign (Nov 01, 2022) | |||
1-1704138-A-G | Likely benign (Nov 01, 2022) | |||
1-1704238-G-A | Likely benign (Jan 01, 2023) | |||
1-1704272-C-T | not specified | Uncertain significance (Jan 25, 2023) | ||
1-1704291-C-T | not specified | Uncertain significance (Apr 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDK11A | protein_coding | protein_coding | ENST00000404249 | 19 | 21598 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.38e-17 | 0.0112 | 124054 | 4 | 583 | 124641 | 0.00236 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.828 | 339 | 299 | 1.13 | 0.0000188 | 5028 |
Missense in Polyphen | 54 | 63.928 | 0.8447 | 1211 | ||
Synonymous | -3.12 | 163 | 120 | 1.36 | 0.00000791 | 1336 |
Loss of Function | 0.316 | 27 | 28.8 | 0.936 | 0.00000155 | 525 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00125 | 0.00125 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000224 | 0.000223 |
Finnish | 0.0123 | 0.0121 |
European (Non-Finnish) | 0.00197 | 0.00189 |
Middle Eastern | 0.000224 | 0.000223 |
South Asian | 0.00206 | 0.00196 |
Other | 0.00291 | 0.00281 |
dbNSFP
Source:
- Function
- FUNCTION: Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. {ECO:0000269|PubMed:12501247, ECO:0000269|PubMed:12624090}.;
- Pathway
- terminal <i>O</i>-glycans residues modification;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.141
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.370
- ghis
- 0.519
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding